{"id":934025,"date":"2026-02-04T11:50:10","date_gmt":"2026-02-04T16:50:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/"},"modified":"2026-02-04T11:50:10","modified_gmt":"2026-02-04T16:50:10","slug":"urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/","title":{"rendered":"UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit"},"content":{"rendered":"
\n

PRINCETON, N.J., Feb. 04, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that management will present at the Guggenheim Securities Emerging Outlook: Biotech Summit to take place on February 11-12, 2026.<\/p>\n

\n Guggenheim Emerging Outlook: Biotech Summit 2026<\/strong>\n <\/p>\n\n\n\n\n\n\n
Date \/ Time:<\/td>\nFebruary 12, 2026, at 2:30 PM ET<\/td>\n<\/tr>\n
Format:<\/td>\nFireside Chat and 1×1 investor meetings<\/td>\n<\/tr>\n
Location:<\/td>\nNew York, NY<\/td>\n<\/tr>\n
Webcast Link:<\/td>\n\n here<\/a>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

The webcast from the conference will also be available on UroGen\u2019s corporate website, under Events & Presentations<\/a>. A replay will be available for approximately 90 days.<\/p>\n

\n About UroGen Pharma Ltd.<\/strong>\n <\/p>\n

UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGel\u00ae<\/sup> reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based platform technology that has the potential to improve the therapeutic profiles of existing drugs. UroGen\u2019s sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen\u2019s first commercial product is approved to treat low-grade upper tract urothelial cancer, and UroGen\u2019s second product is the first and only FDA-approved medication for patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. Both medicines are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, New Jersey with operations in Israel. To learn more, visit www.urogen.com<\/a> or follow us on X (Twitter), @UroGenPharma<\/p>\n

INVESTORS:<\/p>\n

Vincent Perrone
Senior Director, Investor Relations
vincent.perrone@urogen.com<\/a>
609-460-3588 ext. 1093<\/p>\n

MEDIA:<\/p>\n

Cindy Romano
Director, Corporate Communications
cindy.romano@urogen.com<\/a>
609-460-3583 ext. 1083<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PRINCETON, N.J., Feb. 04, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that management will present at the Guggenheim Securities Emerging Outlook: Biotech Summit to take place on February 11-12, 2026. Guggenheim Emerging Outlook: Biotech Summit 2026 Date \/ Time: February 12, 2026, at 2:30 PM ET Format: Fireside Chat and 1×1 investor meetings Location: New York, NY Webcast Link: here \u00a0 \u00a0 The webcast from the conference will also be available on UroGen\u2019s corporate website, under Events & Presentations. A replay will be available for approximately 90 days. About UroGen Pharma Ltd. UroGen is a biotech company dedicated to developing … <\/p>\n

Continue reading “UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-934025","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nUroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J., Feb. 04, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that management will present at the Guggenheim Securities Emerging Outlook: Biotech Summit to take place on February 11-12, 2026. Guggenheim Emerging Outlook: Biotech Summit 2026 Date \/ Time: February 12, 2026, at 2:30 PM ET Format: Fireside Chat and 1×1 investor meetings Location: New York, NY Webcast Link: here \u00a0 \u00a0 The webcast from the conference will also be available on UroGen\u2019s corporate website, under Events & Presentations. A replay will be available for approximately 90 days. About UroGen Pharma Ltd. UroGen is a biotech company dedicated to developing … Continue reading "UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-04T16:50:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODMxOSM3NDA3NzE3IzIwMjkwMTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit\",\"datePublished\":\"2026-02-04T16:50:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/\"},\"wordCount\":285,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0ODMxOSM3NDA3NzE3IzIwMjkwMTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/\",\"name\":\"UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0ODMxOSM3NDA3NzE3IzIwMjkwMTk=\",\"datePublished\":\"2026-02-04T16:50:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0ODMxOSM3NDA3NzE3IzIwMjkwMTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0ODMxOSM3NDA3NzE3IzIwMjkwMTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/","og_locale":"en_US","og_type":"article","og_title":"UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit - Market Newsdesk","og_description":"PRINCETON, N.J., Feb. 04, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that management will present at the Guggenheim Securities Emerging Outlook: Biotech Summit to take place on February 11-12, 2026. Guggenheim Emerging Outlook: Biotech Summit 2026 Date \/ Time: February 12, 2026, at 2:30 PM ET Format: Fireside Chat and 1×1 investor meetings Location: New York, NY Webcast Link: here \u00a0 \u00a0 The webcast from the conference will also be available on UroGen\u2019s corporate website, under Events & Presentations. A replay will be available for approximately 90 days. About UroGen Pharma Ltd. UroGen is a biotech company dedicated to developing … Continue reading \"UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-04T16:50:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODMxOSM3NDA3NzE3IzIwMjkwMTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit","datePublished":"2026-02-04T16:50:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/"},"wordCount":285,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODMxOSM3NDA3NzE3IzIwMjkwMTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/","name":"UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODMxOSM3NDA3NzE3IzIwMjkwMTk=","datePublished":"2026-02-04T16:50:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODMxOSM3NDA3NzE3IzIwMjkwMTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODMxOSM3NDA3NzE3IzIwMjkwMTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-the-guggenheim-securities-emerging-outlook-biotech-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/934025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=934025"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/934025\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=934025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=934025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=934025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}